Kathleen Williamson

Title: Innovations in Cancer Detection by Kathleen Williamson

Introduction

Kathleen Williamson is a notable inventor based in Northern Ireland, GB. She has made significant contributions to the field of cancer detection, particularly focusing on urothelial and bladder cancers. With a total of 2 patents to her name, her work is paving the way for advancements in medical diagnostics.

Latest Patents

Williamson's latest patents include a method for the diagnosis of urothelial cancer. This invention provides a solid-state device that identifies the presence of urothelial cancer in patients by assigning them to sub-populations based on smoking habits. It involves measuring the levels of various biomarkers in samples obtained from the subject and correlating these levels with the likelihood of having urothelial cancer. The second patent focuses on the detection of bladder cancer risk. This method assays for the presence of a combination of at least two biomarkers from a specified panel in patient samples, indicating the presence or risk of bladder cancer.

Career Highlights

Kathleen Williamson is currently associated with Randox Laboratories Limited, where she continues to innovate in the field of medical diagnostics. Her work is instrumental in developing methods that enhance the accuracy of cancer detection, ultimately benefiting patient outcomes.

Collaborations

Some of her notable coworkers include Mark William Ruddock and Cherith N Reid, who contribute to the collaborative efforts at Randox Laboratories Limited.

Conclusion

Kathleen Williamson's contributions to cancer detection through her innovative patents highlight her role as a leading inventor in the medical field. Her work not only advances technology but also aims to improve patient care and outcomes in cancer diagnosis.